| Name | Title | Contact Details |
|---|
Stillwater Insurance Group is a national insurance provider offering a full suite of insurance products and services. We strive to be the most respected insurance provider in the United States by setting and achieving the highest standards in quality products, service, customer experience and claims satisfaction. Stillwater is: Smart - we meet the evolving needs for homeowners, auto and business insurance Fast - We exceed expectations for customer and claims service Strong - Were ready when needed to help our customers get back on their feet We have an A+ accreditation from the Better Business Bureau. This recognizes our commitment to transparency, responsiveness, integrity and delivering on the promises we make. And we have an A- (Excellent) rating from A.M. Best, the leading insurance rating organization.
AAA-Integration is an engineering service company, that emphasis on (Building Quality into Engineering Design). The evolution in engineering-design software during the past decade has permanently changed the engineering design concept. Three-dimensional computer-aided design, manufacturing and engineering (CAD/CAM/CAE) software programs are close to fulfilling their promise to deliver fully integrated design and manufacturing. CAD design software saves time and money in product development by reducing or eliminating the need for physical mock-ups, allowing for early detection of interference between components and enabling quick design iterations that result in product optimization. To further this integration, design engineering is taking new quality assurance concept. Attention to quality in the process-level used to produce engineering designs--in other words, attention to the data produced by digital modeling activities--is proving to be equally fruitful. Practitioners of design quality assurance and control are reaping great benefits by pushing quality awareness earlier into the engineering process.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
In a time when humanity needs to rethink the future to sustain life on this planet, we consider responsible business a necessary game changer. That is why we are a company that offers 100% organic cotton products for customers who seek delicious, sustainable goods of premium quality. We want our products to last long enough to be passed on. We create them to be enjoyed and used. And we insist on developing a new, sustainable standard of designed goods. #design #functionality #longlasting #newstandard #BCorp #GOTS #organic #feelgood